Scott Garland, PACT Pharma CEO

PACT Phar­ma sus­pends sole clin­i­cal tri­al

Ed­i­tor’s note: Fol­low­ing ad­di­tion­al ed­i­to­r­i­al re­view, this ar­ti­cle and head­line have been cor­rect­ed to re­flect that the 51 af­fect­ed em­ploy­ees high­light­ed in the Cal­i­for­nia WARN no­tice were a sub­group of 94 lay­offs pre­vi­ous­ly an­nounced. PACT Phar­ma did not lay off an ad­di­tion­al 51 em­ploy­ees. 

Just a month af­ter bring­ing out the bud­get axe, PACT Phar­ma is now show­ing more of what it has planned next.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.